ETF Holdings Breakdown of MYGN

MYGN institutional holdings

Date	ETF ISIN/Name	Num Shares	Book value
2025-10-17	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	94,171	USD 734,534
2025-10-17	IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc))	112,761	USD 879,536
2025-10-17	IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc))	69,046	USD 538,559 -3.8%
2025-10-17	IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc))	8,828	USD 68,858 -3.8%
Total =		284,806	USD 2,221,487

Book value of shares is calculated on the adjusted close price of each day (row).

News associated with MYGN

Myriad Genetics, Inc. (NASDAQ:MYGN) Receives $14.38 Consensus PT from Analysts

Shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) have been assigned a consensus rating of “Hold” from the sixteen brokerages that are currently covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a sell rating, ten have issued a hold rating and four have assigned a buy rating to the […] - 2025-08-07 03:12:46

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 86,973 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 43.9% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 285,229 shares of the company’s stock after purchasing an additional 86,973 shares […] - 2025-06-05 06:14:55

Squarepoint Ops LLC Acquires 29,524 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)

Squarepoint Ops LLC boosted its position in shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 27.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 138,869 shares of the company’s stock after acquiring an additional 29,524 shares during the period. Squarepoint […] - 2025-05-30 05:34:51

ProShare Advisors LLC Has $370,000 Stake in Myriad Genetics, Inc. (NASDAQ:MYGN)

ProShare Advisors LLC grew its holdings in Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 12.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 26,982 shares of the company’s stock after purchasing an additional 2,933 shares during the period. ProShare Advisors LLC’s holdings […] - 2025-05-29 05:04:50

BNP Paribas Financial Markets Purchases 23,408 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)

BNP Paribas Financial Markets boosted its position in Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 51.1% in the fourth quarter, HoldingsChannel reports. The firm owned 69,183 shares of the company’s stock after buying an additional 23,408 shares during the quarter. BNP Paribas Financial Markets’ holdings in Myriad Genetics were worth $948,000 as of its […] - 2025-05-22 04:28:50

Myriad Genetics, Inc. (NASDAQ:MYGN) Stake Raised by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 4.3% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 197,001 shares of the company’s stock after purchasing an additional 8,073 […] - 2025-05-21 05:40:50

Myriad Genetics, Inc. (NASDAQ:MYGN) Shares Sold by Comerica Bank

Comerica Bank trimmed its holdings in Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 7.2% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 32,747 shares of the company’s stock after selling 2,525 shares during the period. Comerica Bank’s holdings in Myriad […] - 2025-05-16 05:20:57

Tudor Investment Corp ET AL Boosts Stake in Myriad Genetics, Inc. (NASDAQ:MYGN)

Tudor Investment Corp ET AL boosted its holdings in shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 212.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 49,935 shares of the company’s stock after acquiring an additional 33,937 shares […] - 2025-05-08 06:12:54

Hsbc Holdings PLC Buys 9,997 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)

Hsbc Holdings PLC grew its position in Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 49.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 30,214 shares of the company’s stock after purchasing an additional 9,997 shares during the quarter. Hsbc Holdings […] - 2025-05-08 05:22:47

First Trust Advisors LP Sells 46,831 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)

First Trust Advisors LP trimmed its position in shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 25.1% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 139,545 shares of the company’s stock after selling 46,831 shares during the quarter. First Trust Advisors LP […] - 2025-05-06 05:41:06

Dimensional Fund Advisors LP Has $31.15 Million Stock Holdings in Myriad Genetics, Inc. (NASDAQ:MYGN)

Dimensional Fund Advisors LP decreased its stake in Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 6.2% in the fourth quarter, HoldingsChannel reports. The firm owned 2,272,355 shares of the company’s stock after selling 151,122 shares during the period. Dimensional Fund Advisors LP’s holdings in Myriad Genetics were worth $31,154,000 at the end of the […] - 2025-05-06 04:42:53

Analysts Set Myriad Genetics, Inc. (NASDAQ:MYGN) Price Target at $20.61

Shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) have earned an average recommendation of “Hold” from the sixteen analysts that are currently covering the stock, MarketBeat.com reports. Three analysts have rated the stock with a sell rating, seven have given a hold rating and six have assigned a buy rating to the company. […] - 2025-04-29 02:50:53

Legal & General Group Plc Has $3.38 Million Stock Holdings in Myriad Genetics, Inc. (NASDAQ:MYGN)

Legal & General Group Plc decreased its stake in shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 2.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 246,146 shares of the company’s stock after selling 5,363 shares during […] - 2025-04-23 05:58:48

Arrowstreet Capital Limited Partnership Sells 24,519 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)

Arrowstreet Capital Limited Partnership cut its position in Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 13.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 153,062 shares of the company’s stock after selling 24,519 shares during the period. Arrowstreet […] - 2025-04-11 06:07:13

KLP Kapitalforvaltning AS Purchases New Holdings in Myriad Genetics, Inc. (NASDAQ:MYGN)

KLP Kapitalforvaltning AS acquired a new position in Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 18,000 shares of the company’s stock, valued at approximately $247,000. Several other institutional investors and hedge funds have also recently added […] - 2025-04-08 04:32:51

Corebridge Financial Inc. Sells 3,716 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)

Corebridge Financial Inc. decreased its position in Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 7.2% during the fourth quarter, HoldingsChannel.com reports. The fund owned 47,667 shares of the company’s stock after selling 3,716 shares during the quarter. Corebridge Financial Inc.’s holdings in Myriad Genetics were worth $654,000 at the end of the most recent […] - 2025-04-07 04:32:49

Prudential Financial Inc. Sells 126,550 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)

Prudential Financial Inc. lessened its stake in shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 37.7% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 209,131 shares of the company’s stock after selling 126,550 shares during the period. Prudential […] - 2025-04-03 05:18:51

Myriad Genetics (NASDAQ:MYGN) Price Target Cut to $20.00 by Analysts at Scotiabank

Myriad Genetics (NASDAQ:MYGN – Get Free Report) had its target price lowered by Scotiabank from $24.00 to $20.00 in a note issued to investors on Tuesday,Benzinga reports. The firm currently has a “sector outperform” rating on the stock. Scotiabank’s price objective indicates a potential upside of 127.27% from the company’s current price. Several other research […] - 2025-04-03 04:24:52

Myriad Genetics (NASDAQ:MYGN) Stock Rating Upgraded by StockNews.com

StockNews.com upgraded shares of Myriad Genetics (NASDAQ:MYGN – Free Report) from a hold rating to a buy rating in a report released on Tuesday morning. Several other research analysts have also commented on MYGN. Stephens reissued an “equal weight” rating and issued a $20.00 price objective on shares of Myriad Genetics in a research report […] - 2025-03-26 04:38:45

Natixis Advisors LLC Sells 110,685 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)

Natixis Advisors LLC reduced its position in Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 34.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 209,328 shares of the company’s stock after selling 110,685 shares during the quarter. Natixis Advisors LLC […] - 2025-03-24 05:54:59

Victory Capital Management Inc. Has $841,000 Stock Position in Myriad Genetics, Inc. (NASDAQ:MYGN)

Victory Capital Management Inc. lifted its stake in Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 6.4% during the 4th quarter, HoldingsChannel reports. The fund owned 61,341 shares of the company’s stock after buying an additional 3,711 shares during the period. Victory Capital Management Inc.’s holdings in Myriad Genetics were worth $841,000 as of its […] - 2025-03-21 07:10:48

AlphaQuest LLC Sells 5,360 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)

AlphaQuest LLC lowered its holdings in shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 67.0% during the 4th quarter, Holdings Channel.com reports. The firm owned 2,641 shares of the company’s stock after selling 5,360 shares during the quarter. AlphaQuest LLC’s holdings in Myriad Genetics were worth $36,000 at the end of the most […] - 2025-03-21 06:08:54

Myriad Genetics (NASDAQ:MYGN) Downgraded by StockNews.com to “Hold”

StockNews.com cut shares of Myriad Genetics (NASDAQ:MYGN – Free Report) from a buy rating to a hold rating in a research note released on Thursday. A number of other equities research analysts also recently issued reports on the company. Morgan Stanley lowered their price objective on Myriad Genetics from $32.00 to $21.00 and set an […] - 2025-03-14 06:04:51

Myriad Genetics (NASDAQ:MYGN) Given New $11.50 Price Target at Piper Sandler

Myriad Genetics (NASDAQ:MYGN – Free Report) had its price objective cut by Piper Sandler from $14.00 to $11.50 in a research note issued to investors on Tuesday morning,Benzinga reports. They currently have a neutral rating on the stock. Several other equities research analysts have also commented on MYGN. Leerink Partners lowered Myriad Genetics from an […] - 2025-03-05 06:45:04

Handelsbanken Fonder AB Acquires 3,500 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)

Handelsbanken Fonder AB boosted its holdings in Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 12.8% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 30,788 shares of the company’s stock after acquiring an additional 3,500 shares during the quarter. Handelsbanken Fonder AB’s holdings […] - 2025-03-03 06:59:05

Raymond James Reiterates Outperform Rating for Myriad Genetics (NASDAQ:MYGN)

Raymond James reaffirmed their outperform rating on shares of Myriad Genetics (NASDAQ:MYGN – Free Report) in a research report report published on Tuesday,Benzinga reports. They currently have a $19.00 price objective on the stock, down from their previous price objective of $27.00. Other research analysts have also recently issued reports about the company. Bank of […] - 2025-02-26 06:56:56

Myriad Genetics (NASDAQ:MYGN) Hits New 1-Year Low Following Weak Earnings

Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) hit a new 52-week low during trading on Tuesday following a dissappointing earnings announcement. The stock traded as low as $9.76 and last traded at $11.63, with a volume of 405660 shares changing hands. The stock had previously closed at $13.78. The company reported ($0.09) EPS for […] - 2025-02-26 04:20:57

New York State Teachers Retirement System Reduces Stake in Myriad Genetics, Inc. (NASDAQ:MYGN)

New York State Teachers Retirement System trimmed its stake in Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 4.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 70,598 shares of the company’s stock after selling 3,302 shares during the […] - 2025-02-24 06:26:57

KBC Group NV Purchases 3,334 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)

KBC Group NV raised its stake in shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 132.8% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 5,845 shares of the company’s stock after buying an additional 3,334 shares during the quarter. KBC Group […] - 2025-02-10 16:33:12

Jennison Associates LLC Raises Holdings in Myriad Genetics, Inc. (NASDAQ:MYGN)

Jennison Associates LLC boosted its stake in shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 144.2% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 59,015 shares of the company’s stock after acquiring an additional 34,853 shares during the quarter. Jennison Associates […] - 2025-02-07 07:25:00

Back to Listing

Disclaimer